Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 15:54 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
NCT03913559 · St. Jude Children's Research Hospital · PHASE2 · terminated · last registry update 2026-02-12 · Childhood acute lymphoblastic leukemia · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Closed due to slow accrual” | – | Registry record, St. Jude Children's Research Hospital |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CD22 in childhood acute lymphoblastic leukemia within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-07-30Also stopped (terminated): M.D. Anderson Cancer Center, Cyclophosphamide + Cytarabine (NCT03488225)
- 2026-06-24Also stopped (withdrawn): Nantes University Hospital, 90Y-DOTA-Epratuzumab IgG/Epratuzumab IgG + Busulfan (NCT02577094)
- 2026-04-15Results posted on the registry: M.D. Anderson Cancer Center, Bendamustine + Filgrastim-sndz (NCT03856216)
- 2026-04-15Also stopped (terminated): M.D. Anderson Cancer Center, Bendamustine + Filgrastim-sndz (NCT03856216)
- 2026-03-17Phase 3 first posted: Charite University, Berlin, Germany, Inotuzumab ozogamicin (INO) + Blinatumomab (NCT07476729)
- 2025-12-12Also stopped (terminated): M.D. Anderson Cancer Center, ADCT-602 (NCT03698552)
- 2025-09-05Results posted on the registry: M.D. Anderson Cancer Center, Vitamin B Complex (NCT03564678)
- 2025-09-05Also stopped (terminated): M.D. Anderson Cancer Center, Vitamin B Complex (NCT03564678)
- 2025-08-07Results posted on the registry: Pfizer, inotuzumab ozogamicin (NCT05687032)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision